HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

François Ghiringhelli Selected Research

O-cyclopentyl-S-diethylaminoethyl methylphosphonothioate

3/2014Cell-death-associated molecular patterns as determinants of cancer immunogenicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


François Ghiringhelli Research Topics

Disease

145Neoplasms (Cancer)
12/2022 - 12/2003
31Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 03/2010
16Colonic Neoplasms (Colon Cancer)
01/2021 - 04/2004
15Breast Neoplasms (Breast Cancer)
03/2022 - 09/2007
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 01/2017
11Neoplasm Metastasis (Metastasis)
03/2022 - 03/2010
10Melanoma (Melanoma, Malignant)
08/2020 - 02/2006
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2017
5Disease Progression
12/2021 - 10/2010
4Adenocarcinoma
04/2021 - 09/2012
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 06/2009
4Lung Neoplasms (Lung Cancer)
01/2020 - 01/2019
4Inflammation (Inflammations)
01/2020 - 08/2015
4Glioblastoma (Glioblastoma Multiforme)
01/2018 - 10/2009
3COVID-19
11/2022 - 01/2021
3Hyperthermia
11/2022 - 01/2011
3Pain (Aches)
01/2022 - 10/2010
3Hypertension (High Blood Pressure)
12/2021 - 02/2010
3Thrombocytopenia (Thrombopenia)
10/2021 - 01/2013
3Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 01/2011
3Cholangiocarcinoma
01/2021 - 01/2013
3Neutropenia
12/2020 - 01/2013
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
08/2019 - 04/2009
3Sarcoma (Soft Tissue Sarcoma)
01/2019 - 01/2018
3Obesity
12/2017 - 02/2014
3Pancreatic Neoplasms (Pancreatic Cancer)
11/2016 - 09/2012
3Lymphopenia (Lymphocytopenia)
01/2014 - 08/2008
3Residual Neoplasm
06/2010 - 10/2007
2Carcinoma (Carcinomatosis)
03/2022 - 08/2021
2Genomic Instability
03/2022 - 08/2021
2Hypersensitivity (Allergy)
01/2022 - 01/2013
2Diarrhea
01/2022 - 12/2015

Drug/Important Bio-Agent (IBA)

26Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 04/2010
22Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2021 - 02/2010
20Biomarkers (Surrogate Marker)IBA
03/2022 - 09/2007
16Bevacizumab (Avastin)FDA Link
01/2022 - 03/2010
15Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
14Pharmaceutical PreparationsIBA
01/2022 - 02/2010
12AnthracyclinesIBA
10/2016 - 03/2007
11Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2006
11Proteins (Proteins, Gene)FDA Link
10/2019 - 03/2007
10Irinotecan (Camptosar)FDA LinkGeneric
10/2021 - 04/2012
10InflammasomesIBA
11/2020 - 10/2009
9CalreticulinIBA
01/2013 - 01/2007
8CytokinesIBA
01/2022 - 06/2012
8AntigensIBA
01/2020 - 02/2006
8HMGB1 Protein (HMG1)IBA
06/2016 - 09/2007
7DNA (Deoxyribonucleic Acid)IBA
03/2022 - 01/2007
7Leucovorin (Folinic Acid)FDA Link
10/2021 - 09/2012
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 02/2004
6folfirinoxIBA
01/2022 - 09/2012
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2022 - 01/2019
5PlatinumIBA
03/2022 - 01/2011
5Biological ProductsIBA
01/2022 - 08/2008
5Docetaxel (Taxotere)FDA Link
01/2022 - 10/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 01/2011
5Monoclonal AntibodiesIBA
10/2021 - 08/2008
5LigandsIBA
10/2020 - 09/2008
5Peptides (Polypeptides)IBA
01/2020 - 03/2006
5VaccinesIBA
10/2014 - 02/2006
5Adenosine Triphosphate (ATP)IBA
01/2012 - 04/2004
5Neoplasm Antigens (Tumor Antigens)IBA
11/2008 - 02/2006
4ErbB Receptors (EGF Receptor)IBA
06/2022 - 01/2019
4Cetuximab (Erbitux)FDA Link
01/2022 - 02/2016
4AntibodiesIBA
01/2022 - 01/2018
4InterferonsIBA
03/2014 - 02/2006
4GemcitabineFDA Link
01/2013 - 03/2010
4Transforming Growth Factor beta (TGF-beta)IBA
01/2013 - 02/2004
4Toll-Like Receptor 4IBA
10/2008 - 09/2007
4Immunologic Adjuvants (Immunologic Adjuvant)IBA
09/2008 - 09/2007
3Chemokine CXCL10IBA
12/2022 - 01/2022
3Interleukin-4 (Interleukin 4)IBA
01/2022 - 08/2015
3PolyphenolsIBA
01/2020 - 01/2017
3Sunitinib (Sutent)FDA Link
08/2019 - 01/2016
3Imatinib Mesylate (Gleevec)FDA Link
08/2019 - 04/2009
3afliberceptIBA
02/2019 - 12/2015
3NivolumabIBA
01/2019 - 01/2017
3Temozolomide (Temodar)FDA LinkGeneric
01/2018 - 10/2009
3Interleukin-9 (Interleukin 9)IBA
01/2017 - 02/2015
3Interleukin-17 (Interleukin 17)IBA
01/2017 - 03/2011
3Trastuzumab (Herceptin)FDA Link
10/2016 - 01/2011
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
06/2016 - 01/2015
3Dacarbazine (DIC)FDA LinkGeneric
01/2014 - 02/2013
3ResveratrolIBA
07/2013 - 01/2011
3Reactive Oxygen Species (Oxygen Radicals)IBA
04/2013 - 04/2004
3Therapeutic UsesIBA
02/2013 - 12/2007
3Interferon-gamma (Interferon, gamma)IBA
02/2010 - 09/2008
2HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
11/2022 - 04/2006
2Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2022 - 04/2006
2GoldIBA
01/2022 - 04/2021
2Mitogen-Activated Protein KinasesIBA
01/2022 - 01/2019
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2021 - 01/2019

Therapy/Procedure

80Drug Therapy (Chemotherapy)
12/2022 - 04/2004
47Therapeutics
03/2022 - 02/2006
20Immunotherapy
12/2022 - 02/2004
16Radiotherapy
10/2020 - 03/2007
5Neoadjuvant Therapy
01/2018 - 04/2008
4Aftercare (After-Treatment)
09/2021 - 03/2011
4Adjuvant Chemotherapy
01/2018 - 08/2011
2Duration of Therapy
12/2021 - 01/2018